Details for: ACT ONDANSETRON
Company: TEVA CANADA LIMITED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02296349 | TEVA-ONDANSETRON | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG | TABLET | ORAL |
| 02296357 | TEVA-ONDANSETRON | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 8 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Summary Safety Review - Serotonin blocking drugs (serotonin antagonists) ALOXI® (palonosetron), ANZEMET® (dolasetron), KYTRIL® (granisetron) and generics, and ZOFRAN® (ondansetron) and generics - Serotonin Syndrome
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.